UniProt ID | FHR1_HUMAN | |
---|---|---|
UniProt AC | Q03591 | |
Protein Name | Complement factor H-related protein 1 | |
Gene Name | CFHR1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 330 | |
Subcellular Localization | Secreted. | |
Protein Description | Involved in complement regulation. The dimerized forms have avidity for tissue-bound complement fragments and efficiently compete with the physiological complement inhibitor CFH. Can associate with lipoproteins and may play a role in lipid metabolism.. | |
Protein Sequence | MWLLVSVILISRISSVGGEATFCDFPKINHGILYDEEKYKPFSQVPTGEVFYYSCEYNFVSPSKSFWTRITCTEEGWSPTPKCLRLCFFPFVENGHSESSGQTHLEGDTVQIICNTGYRLQNNENNISCVERGWSTPPKCRSTDTSCVNPPTVQNAHILSRQMSKYPSGERVRYECRSPYEMFGDEEVMCLNGNWTEPPQCKDSTGKCGPPPPIDNGDITSFPLSVYAPASSVEYQCQNLYQLEGNKRITCRNGQWSEPPKCLHPCVISREIMENYNIALRWTAKQKLYLRTGESAEFVCKRGYRLSSRSHTLRTTCWDGKLEYPTCAKR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
126 | N-linked_Glycosylation | RLQNNENNISCVERG EECCCCCCEEEECCC | 22.75 | 18638581 | |
126 | N-linked_Glycosylation | RLQNNENNISCVERG EECCCCCCEEEECCC | 22.75 | 16335952 | |
194 | N-linked_Glycosylation | EVMCLNGNWTEPPQC EEEEECCCCCCCCCC | 41.23 | 16335952 | |
269 | Phosphorylation | CLHPCVISREIMENY CCCCEEECHHHHHHC | 11.94 | 27130503 | |
295 | Phosphorylation | LYLRTGESAEFVCKR EEECCCCCCEEEECC | 34.15 | 24505115 | |
304 | Phosphorylation | EFVCKRGYRLSSRSH EEEECCCCEECCCCC | 16.65 | 29759185 | |
307 | Phosphorylation | CKRGYRLSSRSHTLR ECCCCEECCCCCEEE | 18.08 | 29759185 | |
308 | Phosphorylation | KRGYRLSSRSHTLRT CCCCEECCCCCEEEE | 42.25 | 29759185 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FHR1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FHR1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FHR1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PRDX4_HUMAN | PRDX4 | physical | 21988832 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-126 AND ASN-194, AND MASSSPECTROMETRY. |